The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 350 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. 
For more information please visit ct.catapult.org.uk 

READ THE CATAPULT ANNUAL REVIEW HERE

Download PDF's below

Advanced Therapies Apprenticeships



Creating opportunities across the UK: Annual Review

Cell and gene therapy GMP
manufacturing in the UK:
Capability and capacity analysis

2021 UK Cell and Gene Therapy Skills Demand Survey Report

Contact Us

    #ScotLifeSci21
    © JPIMedia Ltd 2021 All Rights Reserved
    twitter
    Facebook Twitter Google+ LinkedIn